Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M E Gore

Showing results (141-150 of 157) with videos related to

Pageof 16
Sort By:
The British Journal of Dermatology|February 14, 2002
U.K. guidelines for the management of cutaneous melanomaD L L Roberts, A V Anstey, R J Barlow, et al.
The Journal of Clinical Endocrinology and Metabolism|March 30, 2006
A novel point mutation in P450c17 (CYP17) causing combined 17alpha-hydroxylase/17,20-lyase deficiencyA M Brooke, N F Taylor, J H Shepherd, et al.
British Journal of Plastic Surgery|January 11, 2002
UK guidelines for the management of cutaneous melanomaJ A N Bishop, P G Corrie, J Evans, et al.
The British Journal of Dermatology|July 9, 2010
Revised U.K. guidelines for the management of cutaneous melanoma 2010J R Marsden, J A Newton-Bishop, L Burrows, et al.
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS|August 24, 2010
Revised UK guidelines for the management of cutaneous melanoma 2010J R Marsden, J A Newton-Bishop, L Burrows, et al.
Lancet (London, England)|February 24, 2001
Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinomaI Vergote, J De Brabanter, A Fyles, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 23, 2009
A feasibility study of sequential doublet chemotherapy comprising carboplatin-doxorubicin and carboplatin-paclitaxel for advanced endometrial adenocarcinoma and carcinosarcomaJ E Ang, R N Shah, M Everard, et al.
Cancer|May 18, 1999
Treatment of nondysgerminomatous ovarian germ cell tumors: an analysis of 69 casesP L Mitchell, N Al-Nasiri, R A'Hern, et al.
European Journal of Cancer (Oxford, England : 1990)|March 20, 2012
Evaluation of treatment options for patients with advanced renal cell carcinoma: assessment of appropriateness, using the validated semi-quantitative RAND corporation/University of California, Los Angeles methodologyM E Gore, J Bellmunt, T Eisen, et al.
British Journal of Cancer|January 18, 2014
Efficacy and safety of sunitinib in elderly patients with metastatic renal cell carcinomaT E Hutson, R M Bukowski, B I Rini, et al.
Pageof 16

Showing results (141-150 of 157) with videos related to

Sort By:
Pageof 16
The British Journal of Dermatology|February 14, 2002
U.K. guidelines for the management of cutaneous melanomaD L L Roberts, A V Anstey, R J Barlow, et al.
The Journal of Clinical Endocrinology and Metabolism|March 30, 2006
A novel point mutation in P450c17 (CYP17) causing combined 17alpha-hydroxylase/17,20-lyase deficiencyA M Brooke, N F Taylor, J H Shepherd, et al.
British Journal of Plastic Surgery|January 11, 2002
UK guidelines for the management of cutaneous melanomaJ A N Bishop, P G Corrie, J Evans, et al.
The British Journal of Dermatology|July 9, 2010
Revised U.K. guidelines for the management of cutaneous melanoma 2010J R Marsden, J A Newton-Bishop, L Burrows, et al.
Journal of Plastic, Reconstructive & Aesthetic Surgery : JPRAS|August 24, 2010
Revised UK guidelines for the management of cutaneous melanoma 2010J R Marsden, J A Newton-Bishop, L Burrows, et al.
Lancet (London, England)|February 24, 2001
Prognostic importance of degree of differentiation and cyst rupture in stage I invasive epithelial ovarian carcinomaI Vergote, J De Brabanter, A Fyles, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 23, 2009
A feasibility study of sequential doublet chemotherapy comprising carboplatin-doxorubicin and carboplatin-paclitaxel for advanced endometrial adenocarcinoma and carcinosarcomaJ E Ang, R N Shah, M Everard, et al.
Cancer|May 18, 1999
Treatment of nondysgerminomatous ovarian germ cell tumors: an analysis of 69 casesP L Mitchell, N Al-Nasiri, R A'Hern, et al.
European Journal of Cancer (Oxford, England : 1990)|March 20, 2012
Evaluation of treatment options for patients with advanced renal cell carcinoma: assessment of appropriateness, using the validated semi-quantitative RAND corporation/University of California, Los Angeles methodologyM E Gore, J Bellmunt, T Eisen, et al.
British Journal of Cancer|January 18, 2014
Efficacy and safety of sunitinib in elderly patients with metastatic renal cell carcinomaT E Hutson, R M Bukowski, B I Rini, et al.
Pageof 16